Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Polaris Market Research | PRODUCT CODE: 1831765

Cover Image

PUBLISHER: Polaris Market Research | PRODUCT CODE: 1831765

Clinical Laboratory Tests Market Size, Share, Trends, & Industry Analysis Report By Type (Blood Count, HGB/HCT, Basic Metabolic Panel), By End Use, and By Region - Market Forecast, 2025-2034

PUBLISHED:
PAGES: 125 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 4250
PDF (Multi User License)
USD 5250
PDF (Enterprise License)
USD 6250

Add to Cart

The clinical laboratory tests market size is expected to reach USD 287.12 billion by 2034, according to a new study by Polaris Market Research. The report "Clinical Laboratory Tests Market Share, Size, Trends, Industry Analysis Report: By Type (Blood Count, HGB/HCT, Basic Metabolic Panel), By End Use, and By Region; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Clinical laboratory tests are defined as systematic diagnostic evaluations conducted to assess health status, detect abnormalities, and guide medical decisions. The rising integration of automation and digital technologies in laboratory operations, which enhances efficiency, accuracy, and turnaround times, drives the market expansion. Automated analyzers, AI-driven data interpretation, and advanced informatics systems are streamlining workflows and reducing human errors, making diagnostics more reliable. This technological transformation improves patient outcomes and also addresses the growing demand for high-throughput testing in modern healthcare systems.

The clinical laboratory tests market is driven by the rising focus on personalized medicine, which requires advanced diagnostics tailored to individual patient profiles. Laboratory testing has a central role in identifying biomarkers, genetic predispositions, and treatment responses, thereby supporting targeted therapies. The growing adoption of precision healthcare is fueling demand for specialized and vast tests that go beyond routine diagnostics. This shift towards patient-centric solutions is reinforcing the strategic importance of laboratory services in delivering effective, customized medical care.

Clinical Laboratory Tests Market Report Highlights

In terms of type, the HbA1c tests segment held a 16.42% revenue share in 2024, driven by rising diabetes rates and a growing focus on long-term glucose monitoring.

Based on end use, the primary clinics segment is projected to grow at a robust 8.6% CAGR, driven by demand for point-of-care testing and better diagnostic access.

North America held a dominant 40.47% global market share in 2024, due to its advanced infrastructure and adoption of new diagnostic technologies.

The Asia Pacific market is forecasted to grow at a 9.7% CAGR from 2025 to 2034, driven by urbanization and increasing healthcare spending.

A few global key market players include Abbott Laboratories; ARUP Laboratories; Biosino Bio-Technology and Science Inc.; Charles River Laboratories; Fresenius Medical Care; Genoptix, Inc.; Healthscope Ltd.; Laboratory Corporation of America Holdings (LabCorp); Merck KgaA; NeoGenomics Laboratories, Inc.; OPKO Health, Inc.; QIAGEN; Quest Diagnostics; Siemens Healthineers AG; Sonic Healthcare; and Tulip Diagnostics (P) Ltd.

Polaris Market Research has segmented the market report on the basis of type, end use, and region:

By Type Outlook (Revenue, USD Billion, 2020-2034)

Complete Blood Count

HGB/HCT

Basic Metabolic Panel

BUN Creatinine Tests

Electrolytes Testing

HbA1c Tests

Comprehensive Metabolic Panel

Liver Panel

Renal Panel

Lipid Panel

By End Use Outlook (Revenue, USD Billion, 2020-2034)

Central Laboratories

Primary Clinics

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

US

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Vietnam

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa

Product Code: PM1854

Table of Contents

Chapter 1. Introduction

  • 1.1 Report Description
    • 1.1.1 Objectives of the Study
    • 1.1.2 Market Scope
    • 1.1.3 Assumptions
  • 1.2 Stakeholders

Chapter 2. Executive Summary

Chapter 3. Research Methodology

  • 3.1 Overview
    • 3.1.1 Data Mining
  • 3.2 Data Sources
    • 3.2.1 Primary Sources
    • 3.2.2 Secondary Sources

Chapter 4. Clinical Laboratory Tests Market Insights

  • 4.1 Clinical Laboratory Tests - Industry snapshot
  • 4.1 Clinical Laboratory Tests Market Dynamics
    • 4.1.1 Drivers and Opportunities
      • 4.1.1.1 Rapid innovations in the Clinical Laboratory Tests
      • 4.1.1.2 Rising Geriatric Population and Rising Prevalence Of Target Diseases
    • 4.1.2 Restraints and Challenges
      • 4.1.2.1 High Procedure Costs and Presence of Ambiguous Regulatory Framework
  • 4.2 Clinical Laboratory Tests Market - Porter's Five Forces
    • 4.2.1 Bargaining Power of Suppliers (Moderate)
    • 4.2.2 Threats of New Entrants: (Moderate)
    • 4.2.3 Bargaining Power of Buyers (High)
    • 4.2.4 Threat of Substitute (Low)
    • 4.2.5 Rivalry among existing firms (High)
  • 4.3 Political, Economic, Social, and Technological (PEST) Analysis
  • 4.4 Covid-19 Impact Analysis & Industry Trends

Chapter 5. Clinical Laboratory Tests Market Assessment by Type

  • 5.1 Introduction
  • 5.2 Complete Blood Count
  • 5.3 HGB/HCT
  • 5.4 Basic Metabolic Panel
  • 5.5 BUN Creatinine Tests
  • 5.6 Electrolytes Testing
  • 5.7 HbA1c Tests
  • 5.8 Comprehensive Metabolic Panel
  • 5.9 Liver Panel
  • 5.10 Renal Panel
  • 5.11 Lipid Panel

Chapter 6. Clinical Laboratory Tests Market Assessment by End-Use

  • 6.1 Introduction
  • 6.2 Central Laboratories
  • 6.3 Primary Clinics

Chapter 7. Clinical Laboratory Tests Market Assessment by Region

  • 7.1 Introduction
  • 7.2 Clinical Laboratory Tests Market - North America
    • 7.2.1 Clinical Laboratory Tests Market - U.S.
    • 7.2.2 Clinical Laboratory Tests Market - Canada
  • 7.3 Clinical Laboratory Tests Market - Europe
    • 7.3.1 Clinical Laboratory Tests Market - Germany
    • 7.3.2 Clinical Laboratory Tests Market - UK
    • 7.3.3 Clinical Laboratory Tests Market - France
    • 7.3.4 Clinical Laboratory Tests Market - Italy
    • 7.3.5 Clinical Laboratory Tests Market - Spain
    • 7.3.6 Clinical Laboratory Tests Market - Netherlands
    • 7.3.7 Clinical Laboratory Tests Market - Austria
  • 7.4 Clinical Laboratory Tests Market - Asia Pacific
    • 7.4.1 Clinical Laboratory Tests Market - China
    • 7.4.2 Clinical Laboratory Tests Market - India
    • 7.4.3 Clinical Laboratory Tests Market - Japan
    • 7.4.4 Clinical Laboratory Tests Market - Indonesia
    • 7.4.5 Clinical Laboratory Tests Market - Malaysia
    • 7.4.6 Clinical Laboratory Tests Market - South Korea
  • 7.5 Clinical Laboratory Tests Market - Latin America
    • 7.5.1 Clinical Laboratory Tests Market - Brazil
    • 7.5.2 Clinical Laboratory Tests Market - Mexico
  • 7.6 Clinical Laboratory Tests Market - Middle East & Africa
    • 7.6.1 Clinical Laboratory Tests Market - Saudi Arabia
    • 7.6.2 Clinical Laboratory Tests Market - UAE

Chapter 8. Company Profiles

  • 8.1 Abbott Laboratories
    • 8.1.1 Business Overview
    • 8.1.2 Financial Snapshot
    • 8.1.3 Products and Services
    • 8.1.4 Recent Developments
  • 8.2 ARUP Laboratories
    • 8.2.1 Business Overview
    • 8.2.2 Products and Services
    • 8.2.3 Recent Developments
  • 8.3 OPKO Health, Inc.
    • 8.3.1 Business Overview
    • 8.3.2 Financial Snapshot
    • 8.3.3 Products and Services
    • 8.3.4 Recent Developments
  • 8.4 NeoGenomics Laboratories, Inc.
    • 8.4.1 Business Overview
    • 8.4.2 Financial Snapshot
    • 8.4.3 Products and Services
    • 8.4.4 Recent Developments
  • 8.5 Genoptix, Inc.
    • 8.5.1 Business Overview
    • 8.5.2 Products and Services
  • 8.6 Healthscope Ltd.
    • 8.6.1 Business Overview
    • 8.6.2 Products and Services
  • 8.7 Laboratory Corporation of America Holdings (LabCorp)
    • 8.7.1 Business Overview
    • 8.7.2 Financial Snapshot
    • 8.7.3 Products and Services
    • 8.7.4 Recent Developments
  • 8.8 Fresenius Medical Care
    • 8.8.1 Business Overview
    • 8.8.2 Financial Snapshot
    • 8.8.3 Products and Services
    • 8.8.4 Recent Developments
  • 8.9 Quest Diagnostics
    • 8.9.1 Business Overview
    • 8.9.2 Financial Snapshot
    • 8.9.3 Products and Services
    • 8.9.4 Recent Developments
  • 8.10 Sonic Healthcare
    • 8.10.1 Business Overview
    • 8.10.2 Financial Snapshot
    • 8.10.3 Products and Services
  • 8.11 QIAGEN
    • 8.11.1 Business Overview
    • 8.11.2 Financial Snapshot
    • 8.11.3 Products and Services
  • 8.12 Siemens Healthineers AG
    • 8.12.1 Business Overview
    • 8.12.2 Financial Snapshot
    • 8.12.3 Products and Services
  • 8.13 Merck KgaA
    • 8.13.1 Business Overview
    • 8.13.2 Financial Snapshot
    • 8.13.3 Products and Services
  • 8.14 Tulip Diagnostics (P) Ltd.
    • 8.14.1 Business Overview
    • 8.14.2 Products and Services
    • 8.14.3 Recent Developments
  • 8.15 Biosino Bio-Technology and Science Inc.
    • 8.15.1 Business Overview
    • 8.15.2 Financial Snapshot
    • 8.15.3 Products and Services
  • 8.16 Charles River Laboratories
    • 8.16.1 Business Overview
    • 8.16.2 Financial Snapshot
    • 8.16.3 Products and Services
Product Code: PM1854

List of Tables

  • Table 1 North America diabetes prevalence (national prevalence %), 2024 & 2034
  • Table 2 Europe diabetes prevalence (national prevalence %), 2024 & 2034
  • Table 3 Asia Pacific diabetes prevalence (national prevalence %), 2024 & 2034
  • Table 4 Latin America Diabetes Prevalence (national prevalence %), 2024 & 2034
  • Table 5 MEA and Africa diabetes prevalence (national prevalence %), 2024 & 2034
  • Table 6 CIS diabetes prevalence (national prevalence %), 2024 & 2034
  • Table 7 Global Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
  • Table 1 Global Clinical Laboratory Tests Market, by Complete Blood Count, 2021 - 2034 (USD Billion)
  • Table 2 Global Clinical Laboratory Tests Market, by HGB/HCT, 2021 - 2034 (USD Billion)
  • Table 3 Global Clinical Laboratory Tests Market, by Basic Metabolic Panel, 2021 - 2034 (USD Billion)
  • Table 4 Global Clinical Laboratory Tests Market, by BUN Creatinine Tests, 2021 - 2034 (USD Billion)
  • Table 5 Global Clinical Laboratory Tests Market, by Electrolytes Testing, 2021 - 2034 (USD Billion)
  • Table 6 Global Clinical Laboratory Tests Market, by HbA1c Tests, 2021 - 2034 (USD Billion)
  • Table 7 Global Clinical Laboratory Tests Market, by Comprehensive Metabolic Panel, 2021 - 2034 (USD Billion)
  • Table 8 Global Clinical Laboratory Tests Market, by Liver Panel, 2021 - 2034 (USD Billion)
  • Table 9 Global Clinical Laboratory Tests Market, by Renal Panel, 2021 - 2034 (USD Billion)
  • Table 10 Global Clinical Laboratory Tests Market, by Lipid Panel, 2021 - 2034 (USD Billion)
  • Table 11 Global Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
  • Table 12 Global Clinical Laboratory Tests Market, by Central Laboratories, 2021 - 2034 (USD Billion)
  • Table 13 Global Clinical Laboratory Tests Market, by Primary Clinics, 2021 - 2034 (USD Billion)
  • Table 14 Clinical Laboratory Tests Market Assessment, By Geography, 2021 - 2034 (USD Billion)
  • Table 15 North America Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
  • Table 16 North America Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
  • Table 17 U.S. Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
  • Table 18 U.S. Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
  • Table 19 Canada Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
  • Table 20 Canada Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
  • Table 21 Europe Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
  • Table 22 Europe Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
  • Table 23 Germany Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
  • Table 24 Germany Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
  • Table 25 UK Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
  • Table 26 UK Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
  • Table 27 France Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
  • Table 28 France Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
  • Table 29 Italy Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
  • Table 30 Italy Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
  • Table 31 Spain Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
  • Table 32 Spain Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
  • Table 33 Netherlands Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
  • Table 34 Netherlands Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
  • Table 35 Austria Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
  • Table 36 Austria Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
  • Table 37 Asia Pacific Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
  • Table 38 Asia Pacific Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
  • Table 39 China Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
  • Table 40 China Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
  • Table 41 India Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
  • Table 42 India Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
  • Table 43 Japan Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
  • Table 44 Japan Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
  • Table 45 Indonesia Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
  • Table 46 Indonesia Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
  • Table 47 Malaysia Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
  • Table 48 Malaysia Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
  • Table 49 South Korea Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
  • Table 50 South Korea Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
  • Table 51 Latin America Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
  • Table 52 Latin America Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
  • Table 53 Brazil Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
  • Table 54 Brazil Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
  • Table 55 Mexico Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
  • Table 56 Mexico Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
  • Table 57 Middle East & Africa Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
  • Table 58 Middle East & Africa Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
  • Table 59 Saudi Arabia Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
  • Table 60 Saudi Arabia Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
  • Table 61 UAE Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
  • Table 62 UAE Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)

List of Figures

  • Figure 1. Executive Summary
  • Figure 2. Research Methodology: Top Down & Bottom-Up Approach
  • Figure 3. Market by Geography, 2017 - 2028 (USD Billion)
  • Figure 4. Global percentage of population, by age group, 2000 and 2050
  • Figure 5. Population over the age of 65 years, by region, 2010 and 2050
  • Figure 6. Diabetes prevalence of top 10 countries in 2013 in the age group of 20 to 79 years (million)
  • Figure 7. Current and projected prevalence of diabetes, by geography, 2024 & 2034 (% increase)
  • Figure 8. Porter's Five Forces
  • Figure 9. Political, Economic, Social, and Technological (PEST) Analysis
  • Figure 10. Market by Type
  • Figure 11. Global Clinical Laboratory Tests Market, By Type, 2025 & 2034 (USD Billion)
  • Figure 12. Market by End-Use
  • Figure 13. Global Clinical Laboratory Tests Market, By End-Use, 2025 & 2034 (USD Billion)
  • Figure 14. Clinical Laboratory Tests Market Assessment, By Geography, 2025 & 2034 (USD Billion)
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!